4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Nutriband Inc. (NTRB) operates in the Biotechnology industry and is headquartered in Orlando, United States. Its market capitalization is roughly $37 million. In the fiscal year ended 2026-01-31, NTRB reported $2M in revenue and ($8M) in net income.
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate.
Interactive charts & full statements → Open the NTRB valuation workbench →
| Income statement | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|
| Total Revenue | $2M | $2M | $2M | $2M | — |
| Gross Profit | $1M | $1M | $1M | $1M | — |
| Operating Income (EBIT) | ($8M) | ($7M) | ($5M) | ($4M) | — |
| Net Income | ($8M) | ($10M) | ($6M) | ($4M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $1M | $1M | — | — |
| Gross Profit | $0M | $0M | $0M | $0M | $0M | — | — |
| Operating Income (EBIT) | ($1M) | ($1M) | ($4M) | ($2M) | ($1M) | — | — |
| Net Income | ($1M) | ($1M) | ($4M) | ($2M) | ($1M) | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|
| Total Assets | $8M | $8M | $8M | $10M | — |
| Total Liabilities | $1M | $1M | $1M | $1M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NTRB viewer.
About TickerBase · Data methodology & sources